| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
|
Earl, Helena M
|
|
|
18 |
6 |
p. 755-769
|
article
|
| 2 |
Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study
|
Atkin, Wendy
|
|
|
18 |
6 |
p. 823-834
|
article
|
| 3 |
Adopting a new stance on immunotherapy for uveal melanoma
|
Komatsubara, Kimberly M
|
|
|
18 |
6 |
p. 702-704
|
article
|
| 4 |
A new standard of care or just another option for patients with relapsed ovarian cancer?
|
Harter, Philipp
|
|
|
18 |
6 |
p. 701-702
|
article
|
| 5 |
Art and emotion in health care
|
Zektzer, Carly
|
|
|
18 |
6 |
p. 716
|
article
|
| 6 |
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
|
Coleman, Robert L
|
|
|
18 |
6 |
p. 779-791
|
article
|
| 7 |
Brigatinib effective in ALK-positive non-small-cell lung cancer
|
Das, Manjulika
|
|
|
18 |
6 |
p. e310
|
article
|
| 8 |
Cancer Drugs Fund of minimal benefit
|
Burki, Talha Khan
|
|
|
18 |
6 |
p. e305
|
article
|
| 9 |
Cancer Rhapsody
|
Mariotti, Laura
|
|
|
18 |
6 |
p. 715
|
article
|
| 10 |
Can post-polypectomy surveillance be less intensive?
|
Winawer, Sidney J
|
|
|
18 |
6 |
p. 707-709
|
article
|
| 11 |
CAR T-cell therapy effective in B acute lymphoblastic leukaemia
|
Wang, Mai
|
|
|
18 |
6 |
p. e314
|
article
|
| 12 |
Challenges behind proving efficacy of adjuvant chemotherapy after preoperative chemoradiation for rectal cancer
|
Carvalho, Carlos
|
|
|
18 |
6 |
p. e354-e363
|
article
|
| 13 |
Chernobyl's tomb
|
Burki, Talha Khan
|
|
|
18 |
6 |
p. 718
|
article
|
| 14 |
Correction to Lancet Oncol 2017; 18: 719–31
|
|
|
|
18 |
6 |
p. e301
|
article
|
| 15 |
Correction to Lancet Oncol 2017; 18: 63–74
|
|
|
|
18 |
6 |
p. e301
|
article
|
| 16 |
Correction to Lancet Oncol 2017; 18: 812
|
|
|
|
18 |
6 |
p. e301
|
article
|
| 17 |
Cracking the cancer code: a personalised genomic approach
|
Lucas, Catherine
|
|
|
18 |
6 |
p. 717
|
article
|
| 18 |
Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy?
|
Shah, Ravi M
|
|
|
18 |
6 |
p. e291
|
article
|
| 19 |
Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? – Authors' reply
|
Schmiegelow, Kjeld
|
|
|
18 |
6 |
p. e292
|
article
|
| 20 |
Electronic cigarette use in the UK
|
Burki, Talha Khan
|
|
|
18 |
6 |
p. e311
|
article
|
| 21 |
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
|
Weller, Michael
|
|
|
18 |
6 |
p. e315-e329
|
article
|
| 22 |
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
|
Pace, Andrea
|
|
|
18 |
6 |
p. e330-e340
|
article
|
| 23 |
European Association for the Study of the Liver: International Liver Congress 2017 Meeting
|
Fricker, Janet
|
|
|
18 |
6 |
p. 713
|
article
|
| 24 |
Evolving adoptive cellular therapies in urological malignancies
|
Wong, Yien Ning Sophia
|
|
|
18 |
6 |
p. e341-e353
|
article
|
| 25 |
Evolving health-care regulations in China
|
Ouyang, Yadan
|
|
|
18 |
6 |
p. 714
|
article
|
| 26 |
“Finding NEMO” in NRAS-mutant melanoma: a step towards a sequential strategy?
|
Bersanelli, Melissa
|
|
|
18 |
6 |
p. e298
|
article
|
| 27 |
Genetics of gallbladder cancer
|
Hemminki, Kari
|
|
|
18 |
6 |
p. e296
|
article
|
| 28 |
Genetics of gallbladder cancer – Authors' reply
|
Mhatre, Sharayu
|
|
|
18 |
6 |
p. e297
|
article
|
| 29 |
Glio, and the family Stone
|
Morgan, Jules
|
|
|
18 |
6 |
p. 715
|
article
|
| 30 |
Graphing individual cancer experiences with Cancergraph
|
Jenkins, Emily
|
|
|
18 |
6 |
p. 718
|
article
|
| 31 |
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|
Gronchi, Alessandro
|
|
|
18 |
6 |
p. 812-822
|
article
|
| 32 |
HPV-related oropharyngeal carcinoma de-escalation protocols
|
Mesía, Ricard
|
|
|
18 |
6 |
p. 704-705
|
article
|
| 33 |
Improving childhood cancer care in Latin America and the Caribbean: a PAHO Childhood Cancer Working Group position statement
|
Denburg, Avram
|
|
|
18 |
6 |
p. 709-711
|
article
|
| 34 |
Incidence and prognosis of carcinoid syndrome: hormones or tumour burden?
|
Zandee, Wouter T
|
|
|
18 |
6 |
p. e299
|
article
|
| 35 |
Incidence and prognosis of carcinoid syndrome: hormones or tumour burden? – Authors' reply
|
Halperin, Daniel M
|
|
|
18 |
6 |
p. e300
|
article
|
| 36 |
International incidence of childhood cancer, 2001–10: a population-based registry study
|
Steliarova-Foucher, Eva
|
|
|
18 |
6 |
p. 719-731
|
article
|
| 37 |
Malignancy in a child or something else?
|
Hoyer-Kuhn, Heike
|
|
|
18 |
6 |
p. e364
|
article
|
| 38 |
Naldemedine effective in treating opioid-induced constipation
|
Brower, Vicki
|
|
|
18 |
6 |
p. e306
|
article
|
| 39 |
Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here?
|
van der Graaf, Winette T A
|
|
|
18 |
6 |
p. 706-707
|
article
|
| 40 |
Neoadjuvant chemotherapy: survival benefit in gastric cancer
|
Das, Manjulika
|
|
|
18 |
6 |
p. e307
|
article
|
| 41 |
New drug-transfer device reduces hazardous exposure
|
Gourd, Elizabeth
|
|
|
18 |
6 |
p. e312
|
article
|
| 42 |
Pfizer to make palbociclib temporarily free on NHS
|
Burki, Talha Khan
|
|
|
18 |
6 |
p. e309
|
article
|
| 43 |
Pregnancy complications in survivors of childhood cancer
|
Brower, Vicki
|
|
|
18 |
6 |
p. e303
|
article
|
| 44 |
Preventing prevention: Indian politics and public health clash
|
The Lancet Oncology,
|
|
|
18 |
6 |
p. 695
|
article
|
| 45 |
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
|
Chen, Allen M
|
|
|
18 |
6 |
p. 803-811
|
article
|
| 46 |
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
|
Alistar, Angela
|
|
|
18 |
6 |
p. 770-778
|
article
|
| 47 |
Selumetinib does not improve survival outcomes in NSCLC
|
Das, Manjulika
|
|
|
18 |
6 |
p. e313
|
article
|
| 48 |
Short-course radiotherapy with delayed surgery for rectal cancer
|
Xie, Li
|
|
|
18 |
6 |
p. e294
|
article
|
| 49 |
Short-course radiotherapy with delayed surgery for rectal cancer
|
Kurokawa, Tomohiro
|
|
|
18 |
6 |
p. e293
|
article
|
| 50 |
Short-course radiotherapy with delayed surgery for rectal cancer – Authors' reply
|
Erlandsson, Johan
|
|
|
18 |
6 |
p. e295
|
article
|
| 51 |
Switch to exemestane effective in early breast cancer
|
Gourd, Elizabeth
|
|
|
18 |
6 |
p. e308
|
article
|
| 52 |
Targeting metabolism in pancreatic cancer
|
Michalski, Christoph W
|
|
|
18 |
6 |
p. 699-700
|
article
|
| 53 |
The tAnGo fell short of inspiring the audience
|
Mavroudis, Dimitrios
|
|
|
18 |
6 |
p. 698-699
|
article
|
| 54 |
Trastuzumab emtansine in HER2-positive metastatic breast cancer
|
Montemurro, Filippo
|
|
|
18 |
6 |
p. 696-697
|
article
|
| 55 |
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
|
Diéras, Véronique
|
|
|
18 |
6 |
p. 732-742
|
article
|
| 56 |
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
|
Krop, Ian E
|
|
|
18 |
6 |
p. 743-754
|
article
|
| 57 |
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
|
Chandran, Smita S
|
|
|
18 |
6 |
p. 792-802
|
article
|
| 58 |
Treatment options for early-stage Hodgkin's lymphoma
|
Venkatesan, Priya
|
|
|
18 |
6 |
p. e304
|
article
|
| 59 |
Tyrosine kinase-inhibitors and heart failure risk
|
Das, Manjulika
|
|
|
18 |
6 |
p. e302
|
article
|
| 60 |
Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer
|
Tseng, Jennifer
|
|
|
18 |
6 |
p. 711-712
|
article
|
Journal description